Top Markets
Coin of the day
Invivyd, Inc. Invivyd, Inc.

Invivyd, Inc.

IVVD
Ранг среди акций #17262
Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development... Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management and prevention of coronavirus disease. Adagio Therapeutics maintains collaborative agreements with Adimab, LLC to facilitate the identification and enhancement of its exclusive antibodies. Furthermore, it partners with the Scripps Research Institute to conduct studies aimed at uncovering potential vaccine solutions for the prophylaxis, detection, or therapy of influenza or beta coronaviruses. Incorporated in 2020, the company's base of operations is in Waltham, Massachusetts.
Цена акции
$0.873
Рыночная капитализация
$257.19M
Изменение (1 день)
-0.78%
Изменение (1 год)
-15.24%
Страна
US
Торговля Invivyd, Inc. (IVVD)

Категория

История цены акций Invivyd, Inc. (IVVD)
Наивысшая цена закрытия: $0.88 2026-09-01

Наименьшая цена закрытия: $27.68 2021-08-01
История цены акций Invivyd, Inc. с 2021 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) -37.39%
2025 355.72%
2024 -79.42%
2023 46.08%
2022 -91.63%
2021 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$553.36 37.99%
US
$1.06K 49.97%
NL
$155.59 543.18%
US
$122.21 -10.03%
AU
$762.65 8.90%
CH